lg 100268 and dactinomycin

lg 100268 has been researched along with dactinomycin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, K; Mu, YM; Nawata, H; Nishi, Y; Takayanagi, R; Yanase, T1

Other Studies

1 other study(ies) available for lg 100268 and dactinomycin

ArticleYear
Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells.
    Molecular and cellular endocrinology, 2001, Jul-05, Volume: 181, Issue:1-2

    Topics: Aromatase; Cell Division; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Estrone; Female; Granulosa Cell Tumor; Humans; Ligands; Nicotinic Acids; Ovary; Promoter Regions, Genetic; Radioimmunoassay; Receptors, Cytoplasmic and Nuclear; Receptors, FSH; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured

2001